Why the study?
Does medium-chain triglyceride oil or omega-3 fatty acid therapy improve hypertriglyceridemia in a patient with familial chylomicronemia syndrome?
Does medium-chain triglyceride oil or omega-3 fatty acid therapy improve hypertriglyceridemia in a patient with familial chylomicronemia syndrome?
MCT oil and omega-3 fatty acids can normalize fasting plasma triglycerides in a subset of LPL-deficient patients with familial chylomicronemia syndrome who lack structural LPL gene mutations.
No takes yet. Share an insight, caveat, or question.
May support MCT oil or omega-3 in select LPL-deficient FCS; hypothesis-generating and should not yet change practice.
Rouis et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: